GGrantIndex
Sort

64,565 grants matching drug discovery

Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug

$681,374
Kojo Mensa-Wilmot · Kennesaw State University · R01 · FY2022 · AI

Cloud computing platform for virtual screening and drug discovery.

$681,314
Robert J Dockhorn · B-Tech Consulting, Ltd · R44 · FY2014 · GM

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline

$681,302
Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2019 · AI

Optimization of Atypical Antimycobacterial Carbapenem Antibiotics

$681,269
John D Buynak · Southern Methodist University · R01 · FY2025 · AI

Nanofiber Scaffolds for Salivary Gland Regeneration

$681,196
Melinda Larsen · State University Of New York At Albany · R01 · FY2021 · DE

FBPase inhibitors for glycemic control in diabetes

$681,190
Ontogen Corporation · R44 · FY2001 · DK

Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression

$681,007
Steven B Abramson · New York University School Of Medicine · R01 · FY2013 · AR

In Situ Cardiac Infarct Cellular Reprogramming

$681,002
Todd K Rosengart · Baylor College Of Medicine · R01 · FY2015 · HL

The Preparation & Characterization of Refined & Complex Polyolefin Structures

$681,000
K. B Wagener · University Of Florida · · FY2007 · MPS

ANDROGEN RECEPTOR BIOCHIPS--PROSTATE CANCER MANAGEMENT

$680,949
Massachusetts Institute Of Technology · R33 · FY2003 · CA

Clinical Research Design, Epidemiologv and Biostatistics Core

$680,889
William S Weintraub · University Of Delaware · U54 · FY2013 · GM

Selective disruption of histone deacetylase complexes using protein interaction modulators

$680,864
Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2022 · CA

CONTROLLED RELEASE POLYMERS FOR BRAIN TUMORS (U19 CA 528

$680,849
Johns Hopkins University · U19 · FY2000 · CA

Kinases as Therapeutic Targets for Endometriosis

$680,838
Martin M Matzuk · Baylor College Of Medicine · R01 · FY2024 · HD

Optimizing HIV Treatment Monitoring under Resource Constraints

$680,826
Joseph W Hogan · Brown University · R01 · FY2018 · AI

Using opioid industry documents to understand marketing of addictive medications

$680,802
Dorothy Elinor Apollonio · University Of California, San Francisco · R01 · FY2025 · DA

Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer

$680,774
Bogdan Olenyuk · Proteogenomics Research Instit/Sys/ Med · R01 · FY2023 · CA

Biophotonics

$680,707
George Patterson · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2022 · EB

Kinome-guided Targeting of Cooperative Dependencies in BRAF Mutated Colorectal Cancer

$680,600
Jean-Philippe Francois Marie Coppe · University Of California, San Francisco · R01 · FY2025 · CA

Using opioid industry documents to understand marketing of addictive medications

$680,595
Dorothy Elinor Apollonio · University Of California, San Francisco · R01 · FY2024 · DA

Rational design and synthesis of small molecule inhibitors targeting unique pathogenic mechanisms in Gram- and Gram+ bacteria important in UTI

$680,528
James W Janetka · Washington University · U19 · FY2023 · AI

Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling

$680,478
Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE

HTS for copper-activated inhibitors against MRSA

$680,458
Olaf Kutsch · University Of Alabama At Birmingham · R01 · FY2018 · AI

A micromachining fluidic cantilever for single cell advanced patch clamping and cellular characterization using atomic force microscopy

$680,381
Ami Chand · Applied Nanostructures, Inc. · R44 · FY2022 · GM

Epstein-Barr Virus LMP1-Mediated Oncogenecity

$680,363
Elliott D Kieff · Brigham And Women'S Hospital · R01 · FY2014 · CA